January 28, 2026By Kate J. Travis, MDBrexpiprazole’s New ClaimsBrexpiprazole’s uses are expanding beyond its original indications, with new research exploring its role in dementia and PTSD.
January 28, 2026By Amritha Bhat, MBBS, MD, MPH Perinatal Mental HealthWe take a close look at the new FDA panel on antidepressants in pregnancy, treatment guidelines for postpartum psychosis, and the role of zuranolone.
January 28, 2026By Alex Evans, PharmD, MBA.Service Dogs for Veterans With PTSDTrained support dogs offer small yet real gains for veterans, but questions remain about how they compare to emotional support pets
January 28, 2026By Alex Evans, PharmD, MBA.Vitamin D Has Dose-Dependent Effect on Depressive Symptoms
December 28, 2025By Jesse Koskey, MD.Psychiatry Practice Boosters, Fifth Edition (2026) - 4 SA / 10 CME
General PsychiatryKarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change EverythingRead More
How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered PractitionersMay 24, 2024
How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered PractitionersMay 24, 2024
How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered PractitionersMay 24, 2024